Thank you for Subscribing to Apac CIO Outlook Weekly Brief
NNIT: Delivering Agility to the Life Sciences Industry
Digitalization of drug development processes in the life sciences industry has paved the way for improved efficiency, streamlined compliance, and engaging customer experiences. However, mere successful execution of a digital strategy alone does not necessarily guarantee quality and rapid production of pharmaceutical products for these organizations. Analyzing the requirements of life sciences industry and implementing relevant digital technologies is paramount for accelerating drug development while maintaining data security and traceability of a medicine’s origin. To help organizations in the deployment of cutting-edge technologies effectively, NNIT an international IT service provider, delivers IT consultancy services and assists pharmaceutical organizations in increasing their capabilities pertaining to value chain, quality management, serialization, and more.
NNIT amalgamates IT with life sciences to drive the digital transformation of drug manufacturing, business operations, and consultation. By comprehending multiple business needs, NNIT improves clinical trial productivity, increases research and development (R&D) throughput, and accelerates drug production. It also enables the integration of in-house native databases with each other, migration of data from legacy infrastructure to cloud, and optimization of the workflow to decrease a product’s time-to-market interval while maintaining compliance with GxP and other regulations. “With our profound experience and domain expertise, we add value to our clients’ business by making them agile in their day-to-day operations,” adds Jason Zhen Sheng Xing, general manager of NNIT China.
The key differentiating factor of NNIT is its ability to build flexible platforms that align with the evolving drug development prerequisites. In tandem with this, the company uses its proprietary Advising, Building, Operating and Supporting (ABOS) service model to understand clients’ businesses at the commencement of collaborations. Following this, it builds a customized platform for clients and then maintains it for the next five to ten years. During that period, NNIT continues to enhance the platform’s functionalities to provide its clientele a competitive advantage. “The ABOS model offers a comprehensive solution set, thereby improving productivity and efficiency in the manufacturing of drugs,” states Xing.
NNIT understands the importance of quality in the life sciences industry as the output of drug discovery impacts patient safety. Therefore, the company offers a wide range of quality management services such as test, validation, and compliance to optimize outputs, ensuring that its clients’ IT systems are aligned with various regulatory requirements of life sciences sector.
Over the years, quality management has been at the center of NNIT’s competencies; therefore it has garnered a vast clientele, comprising some of the largest pharmaceutical institutions. An illustration of its proficiency in catering to client requirements can be exemplified through a success story that sheds light on its approach to delivering IT solutions. NNIT assisted a client in developing a sophisticated pharmaceutical supply chain platform that caters to several business functions such as online drug orders and drug distribution channel management. Consequently, the client obtained an overview of their business operations and could manage sales activities effectively.
Such outcomes have catalyzed NNIT to further partner with various organizations that are pioneering in virtual reality (VR) to enhance its services and help the most heavily regulated life sciences industry. It is also exploring the potential of artificial intelligence (AI) and robotic process automation (RPA) to minimize the risk of errors in the development of drugs and open new doors to newer business opportunities. “We are committed to collaborating with pharmaceutical organizations by inculcating cutting-edge technologies that include big data, internet of things (IoT), and more into our solutions portfolio to ensure scalability and flexibility in their business operations,” concludes Xing.
NNIT A/S: NNIT acquires fast-growing US company to accelerate delivery of IT services to the international life sciences industry